IRIS
BRUNELLI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.965
Totale 19.965
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.965
Totale 19.965
Salva come PNG Salva come JPEG
Città #
Genova 15.923
Rapallo 2.534
Genoa 1.448
Bordighera 60
Totale 19.965
Salva come PNG Salva come JPEG
Nome #
Update on cardiotoxicity of anti-cancer treatments 165
The vulnerable coronary plaque: update on imaging technologies. 163
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 160
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure 159
Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity 157
Cell-cell bond modulates vascular smooth muscle cell responsiveness to Angiotensin II 155
Perfusional and metabolic effects of nisoldipine as shown by positron emission tomography after acute myocardial infarction 154
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 153
Sublethal Doses of an Anti-erbB2 Antibody Leads to Death by Apoptosis in Cardiomyocytes Sensitized by Low Prosenescent Doses of Epirubicin: The Protective Role of Dexrazoxane. 148
Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. 146
Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols. 144
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 139
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 138
EFFECTS OF RAMIPRIL ON CARDIOVASCULAR AND MICROVASCULAR OUTCOMES IN PEOPLE WITH DIABETES MELLITUS: RESULTS OF THE HOPE STUDY AND MICRO-HOPE SUBSTUDY 134
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 134
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 133
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly 133
C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians 131
CD16+ monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. 131
Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development 131
N-acetyl-cysteine reduces neointimal thickening and procoagulant activity after balloon-induced injury in abdominal aortae of NewZealand white rabbits 130
Cardiovascular effects of antimuscarinic agents in overactive bladder 130
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 130
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 129
Thrombolysis in refractory unstable angina. 128
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2 128
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 127
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 125
Urgent cesarean delivery following a spontaneous coronary artery dissection 124
Comparison of coronary flow reserve estimated by dynamic radionuclide SPECT and multi-detector x-ray CT 124
Increased neutrophil lifespan in patients with congestive heart failure. 122
Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder 122
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 121
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 121
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 120
CYBA polymorphism associated with oxidative stress in Italian patients with early onset of coronary artery disease. 119
Incidence and clinical relevance of primary congenital anomalies of the coronary arteries in children and adults. 119
Detection of the "Crossed Aorta Sign" during Echocardiography before Angiography 119
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 118
The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. 118
Clinical stabilization of patients with unstable angina treated with thrombolytic therapy. 117
INFECTIVE ENDOCARDITIS IN HYPERTROPHIC CARDIOMYOPATHY: PREVALENCE, INCIDENCE AND INDICATIONS FOR ANTIBIOTIC PROPHYLAXIS 116
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 116
Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6. 116
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 116
Protective effects of Resveratrol in an experimental model of abdominal aortic aneurysm induction. 116
ALTERED CELL-FUNCTION ASSOCIATED TO LOSS OF CELL-MATRIX ADHESION: PRELIMINARY DATA ON A RAT AORTIC SMOOTH MUSCLE CELL LINE 115
Anorexia nervosa and heart disease: a systematic review 115
Anterior mitral valve aneurysm is an uncommon complication of aortic valve infective endocarditis: A case report 114
Aberrant Right Subclavian Artery (Arteria Lusoria) Challenging 4-French Homolateral Transradial Coronary Catheterisation in Adulthood 114
Protective effects of carvedilol against doxorubicin-induced apoptosis in cardiac muscle cells 114
Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment. 113
Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure 113
EFFECTS OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, RAMIPRIL, ON CARDIOVASCULAR EVENTS IN HIGH-RISK PATIENTS 112
High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes 111
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices 110
Update on the efficacy of statin treatment in Acute Coronary Syndromes. 109
SOLUBLE FORM OF THE ENDOTHELIAL ADHESION MOLECULECD146 BINDS PREFERENTIALLY PROINFLAMMATORYPROATHEROSCLEROTICCD16+ MONOCYTE SUBSET 107
Predictors of cardiovascular outcome and rehospitalization in elderly patients with heart failure 107
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. 106
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 106
Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina. 105
Association between plasma insulin and angiographically documented significant coronary artery disease. 105
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. 105
LIPOPROTEIN (a) IS INCREASED IN ACUTE CORONARY SYNDROMES(UNSTABLE ANGINA PECTORIS AND MYOCARDIAL INFARCTION) BUT IT IS NOT PREDICTIVE OF THE SEVERITY OF CORONARY LESIONS 105
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy 104
Sudden death after valve-in-valve procedure due to delayed coronary obstruction: A case report 103
The need of developing selective prediction models in elderly patients with heart failure 103
Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells 103
Clinical Characteristics and Long-Term Mortality Rate in Female Patients with Takotsubo Syndrome Compared with Female Patients with ST-Elevation Acute Myocardial Infarction: A Retrospective Study from a Single Center 103
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction 103
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case. 102
Cyba polymorphism associated to oxidative stress in italian patients with early onset coronary artery disease. 4th meeting of the ETRO working party on population genetics of haemostatic risk factors for arterial vascular disease 101
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 101
An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure 101
ERGONOVINE MALEATE TEST DETECTS ANGINAL PATIENTS WITH POORLY REPRODUCIBLE EXERCISE TESTS. 101
OxLDL- and HSP-60 antigen-specific CD8(+) T lymphocytes are detectable in the peripheral blood of patients suffering from coronary artery disease. 101
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 100
Early noninvasive evaluation of coronary flow reserve after angioplasty in the left anterior descending coronary artery identifies patients at high risk of restenosis at follow-up. 100
Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes 99
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia 99
Carvedilol prevents mitochondrial membrane potential loss induced by doxorubicin in cardiomyocytes 98
Systemic levels of oxidative stress and title of autoantibodies in patients with ischemic heart disease at their first clinical manifestation. 98
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase 97
Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device 97
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). 96
Recurrent and residual shunts after patent foramen ovale closure: Results from a long-term transcranial doppler study 96
Comprehensive Imaging Assessment of Right Ventricular Strain in Acute Pulmonary Embolism 96
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 96
Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes. 95
Myostatin: A Playmaker in Chronic Kidney Disease and Vascular Damage 95
Role of cell-cell bond for the viability and the function of vascular smooth muscle cells. 94
Plasmatic Levels of metalloproteinases 2 and 9 are increased in patients with congestive heart failure. 94
Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging). 94
Impact of Central Obesity on the Estimation of Carotid-Femoral Pulse Wave Velocity. 94
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 94
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. 93
Postprandial serum induces apoptosis in endothelial cells: role of plymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity 92
Attivazione del fattore coagulativo XII in pz con angina stabile ed instabile 92
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities 91
Totale 11.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.835
article - articoli 47.379
book - libri 478
conference - conferenze 3.860
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 118
Totale 103.670
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019801 0 0 0 0 0 0 0 0 0 0 440 361
2019/20206.079 227 113 301 403 543 654 884 422 560 1.075 638 259
2020/20211.618 108 143 122 193 117 128 71 142 164 181 112 137
2021/20222.754 59 189 197 363 123 193 138 669 102 262 99 360
2022/20232.993 301 201 32 321 558 492 9 248 478 15 301 37
2023/20241.049 48 178 19 159 107 233 78 88 116 23 0 0
Totale 20.242